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nloaded froStereochemistry is vital for pharmaceutical development and can determine drug efficacy. Herein, 10 pairs of
asymmetric triplex metallohelix enantiomers as a library were used to screen inhibitors of amyloid b (Ab) aggre-
gation via a fluorescent cell–based high-throughput method. Intriguingly, L enantiomers show a stronger inhi-
bition effect than D enantiomers. In addition, the metallohelices with aromatic substituents are more effective
than those without, revealing that these groups play a key role in the Ab interaction. Fluorescence stopped-flow
kinetic studies indicate that binding of the L enantiomer to Ab is much faster than that of the D enantiomer.
Furthermore, studies in enzyme digestion, isothermal titration calorimetry, nuclear magnetic resonance, and
computational docking demonstrate that the enantiomers bind to the central hydrophobic a-helical region of
Ab13–23, although with different modes for the L and D enantiomers. Finally, an in vivo study showed that these
metallohelices extend the life span of the Caenorhabditis elegans CL2006 strain by attenuating Ab-induced tox-
icity. Our work will shed light on the design and screening of a metal complex as an amyloid inhibitor against
Alzheimer’s disease.h
m
 
 o
n
 M
arch 31, 2018
ttp://advances.sciencem
ag.org/INTRODUCTION
Supramolecular chemistry aims at building functional, highly
complex chemical systems from components assembled by inter-
molecular forces (1). It offers an outstanding methodology for the de-
sign and synthesis of complex arrays at the molecular level (1, 2).
Certain self-assemblingmultimetallic coordination complexes, named
helicates, can have a similar size to a-helical peptides, particularly in
terms of their diameter and charge (3, 4), and this can lead to specific
target-binding affinitywith biomolecules (5). Recently, the application
of the supramolecular helical scaffold has receivedmuch attention, in-
cluding studies on asymmetric catalysis (6), antimicrobials (3), anti-
cancer (4, 7), and the targeting of amyloid b (Ab) for the treatment
of Alzheimer’s disease (AD) (5).
AD, the most prevalent age-related dementia, affects more than
30 million people worldwide, and it is estimated that, by 2050, some
106 million people will be afflicted with the disease (8, 9). However,
the exact cause of AD, as well as themolecular mechanisms involved,
has not been fully understood. Emerging evidence has shown that
the origin of neurotoxicity is closely linked to the aggregate process
of Abmonomers to oligomers and then subsequently to fibrils in the
pathogenesis (10, 11). Therefore, immense attention has been paid
toward inhibiting Ab aggregation (12–16) as an effective preventive
and therapeutic method for the treatment of AD. Although consid-
erable achievements have been made in screening inhibitors of Ab
aggregation and toxicity, the complex interactions involved in Ab
aggregation dynamics and morphology (17) are difficult to address
using conventional smallmolecules. Therefore, chiral recognition of the
supramolecular structures may be key to developing an understanding
of the disease and discovering new treatments.Recent studies have demonstrated that forming a-helical inter-
mediates facilitates fibrillization (18–20). An a-helical structure in
the 13 to 23 segment of Ab is predicted to become a b strand identi-
fied as an a/b discordance (21). Because an Ab analog that lacks res-
idues 13 to 23 and results in deficiency of the a/b discordant stretch
does not form detectable amyloid fibrils (22), there may be a causal
connection between a/b discordance and fibril structure. Emerging
evidence suggested that stabilization of helical motif(s) may be a suit-
able target for screening inhibitors of Ab aggregation (5, 23). There-
fore, chiral supramolecules that are capable of binding the a-helical
form may exhibit enantioselectivity on inhibition of Ab aggregation.
As previously reported, chiral helicates, which are synthesized by
symmetric rigid ligands AB-BA (Fig. 1A), can be potential therapeutic
agents (8) for enantioselectively inhibiting Ab aggregation. However,
this symmetric system offers little scope to adjust the structure to inter-
act withAb or to create a library for screeningAb aggregation inhibitors
resulting from the high symmetry and modest functionality of the sys-
tem. Recently, we developed a new strategy whereby directional ligands
AB-CD were used to synthesize optically pure head-to-head-to-tail
(HHT) asymmetric constitutions in the absence of head-to-head-to-
head (HHH) isomers (Fig. 1B). Herein, we strategically prepared a
highly stereoselective self-assembly of diverse, functionalized metallo-
helices with this HHT structure to enantioselectively inhibit Ab aggre-
gation. These metallohelices have amphipathic topology and high,
structure-dependent, selective biological activity. Using a cell-based
high-throughput screening system, these asymmetric triplex metallo-
helices enantioselectively inhibited Ab aggregation. Our work shows
that these metallosupramolecules can act as Ab inhibitors, specifically
targeting the central hydrophobic a/b discordant stretch.RESULTS AND DISCUSSION
Ten pairs of HHT asymmetric metallohelix enantiomers (Fig. 1, C
and D) were synthesized and characterized according to our previ-
ously reported methods (3, 4) and used to screen inhibitors of Ab1 of 10
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 aggregation by a cell-based high-throughput screeningmethod (Fig. 2A)
(5). The high-throughput screen system is constructed by a fusion of
Ab42 to enhanced cyan fluorescent protein (Ab-ECFP). In general,
Ab42 in the Ab-ECFP fusion system aggregates rapidly, which hinders
ECFP folding into its native structure to emit cyan fluorescence. In the
presence of Ab aggregation inhibitors, ECFP in the Ab-ECFP fusion
system folds into its native structure and emit cyan fluorescence.
ECFP, a non-Ab fusion system, was used as a control in our experi-
ments. Almost no fluorescence enhancements were observed for the
non-Ab fusion system with the incubation of metallohelices (fig. S1).
Screening results are shown in Fig. 2 (B and C), and the inhibition
ability of the complex can be estimated by the related fluorescence val-
ue ofAb-ECFP/ECFP. Intriguingly,LA1 andDA1 showed remarkable
enantiomeric differences on inhibition of Ab aggregation, whereas
LB4 and DB4 had the greatest inhibition effect. Therefore, we selected
these two pairs of A1 and B4 as examples for further study.
To investigate the effect of the metallohelices on Ab aggregation
kinetics, we performed a thioflavin T (ThT) fluorescence assay. This
is a widely used assay to study the formation of amyloid fibrils (24–26).
Under our experimental conditions, metallohelices alone did not af-
fect ThT fluorescence (fig. S2). Kinetic analysis of the ThT assay showed
that ThT fluorescence did not increase in the early stages, thus demon-
strating that the aggregation of Ab40 andAb42 was greatly suppressed
with the incubation ofmetallohelices (Fig. 2D and fig. S3). Free ligands
La1 and Lb4, which are components of A1 and B4, showed little inhi-
bition effect on Ab40 aggregation (fig. S4). Fluorescence stopped-flow
kinetic studies (Fig. 2E) showed that the process of LA1 binding to
Ab40 was completed about 0.04 s under our experimental conditions,
which was five times faster than its enantiomer DA1 (about 0.2 s).
Herein, we compared the fibrillation inhibitors mentioned in In-
troduction with the metallohelices used in our study. In comparison
with peptide–organic molecule coassemblies (12), the metallohelices
in our study exhibited better inhibition effect. With 50 mM peptide–
organic molecule coassemblies, the inhibition ratio was 70%. In our
study, the inhibition ratio was up to 80% with 50 mM LB4. Among
the fibrillation inhibitors discussed in Introduction, CdTe nanoparti-
cles (NPs) (15) performed the best inhibition effect. The intensity of
ThT can be decreased by 80%with only 2.5 mMCdTeNPs.With 25 mM
inhibitors, the inhibition ratios were 63 and 80%with polyoxometalate
(POM)/peptide composites (POM@P) (13) and POM-Dawson deriva-
tives (14), respectively. On the basis of the inhibition efficiency, CdTeGuan et al., Sci. Adv. 2018;4 : eaao6718 19 January 2018NPs and POM@P exhibited better inhibition effect than the metallo-
helices used in our study. This could be because one NP may offer
many active sites for interacting with Ab, whereas one metallohelix
can only offer one active site per molecule. Although these NPs haveFig. 1. The structures of metallohelices. (A) Symmetric metallohelices based on rigid ditopic bidentate ligands AB-BA yield D3-symmetric enantiomers [Fe2(AB-BA)3].
(B) The directional ligands AB-CD lead to C1-symmetric HHH and HHT “triplex” architectures. (C and D) Metallohelices self-assembled from various components of a
range of functionalized helices with HHT structure. Me, methyl; napth, naphthyl; Bn, benzyl.Fig. 2. The inhibition ability of metallohelices on Ab. (A) The Ab-ECFP fusion
system used in screening Ab aggregation inhibitors. (B and C) Screening results of
metallohelices A and B from the Ab-ECFP fusion screen system. (D) Aggregation ki-
netics of Ab40 monitored by ThT assay with or without the incubation of A1 and B4.
(E) The stopped-flow kinetic study of Ab and A1. Values show means ± SD, and
independent experiments were performed three times.2 of 10
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 better inhibition activity, NPs are easily aggregated and accumulated in
the body because of their hard degradation. Formetallohelices, they are
stable and highly water-soluble compared to peptide–organic mole-
cules andNPs, and the structures and stereochemistry ofmetallohelices
are adjustable and optimized. They can specifically bind to the central
hydrophobic a-helical region of Ab13–23, showing the potential for
AD treatment.
Median inhibitory concentration (IC50) values can also be estimated
by ThT fluorescence assay (8). As shown in fig. S5, metallohelices A1
and B4 can inhibit Ab40/Ab42 aggregation in a dose-dependent man-
ner. For Ab40, IC50 values were 3.65 mM for LA1, 32.29 mM for DA1,
0.94 mM for LB4, and 2.55 mM for DB4 (table S1). For Ab42, IC50
values were 6.76 mM for LA1, 69.82 mM for DA1, 1.66 mM for LB4,
and 3.72 mM for DB4. These results demonstrated that LA1 and LB4
had stronger inhibition onAb40/Ab42 aggregation than their enantio-
mers DA1 and DB4. Furthermore, the enantioselectivity of A1 was
higher than that of B4. Therefore, there were two features for the me-
tallohelices to inhibit Ab aggregation. First, theL enantiomers showed
higher inhibition effects than the D enantiomers. Second, the metallo-
helices with aromatic substituents are more effective than those with-
out aromatic substituents.
To better compare the inhibitory effects of the asymmetric triplex
metallohelices and the previously reported symmetric systems, we
summarized their IC50 values in table S1. The asymmetric metallo-
helixLB4 showed a higher inhibition effect than the symmetric archi-
tectures, whereas the chiral discrimination of A1 is the most obvious.
This may be due to the nature of the asymmetric fold of the triplex
metallohelices, which creates a distinctly amphipathic architecture, re-
miniscent of a-helical peptides (4).
We also investigated the inhibition of Ab40 aggregation by an
SDS–polyacrylamide gel electrophoresis (PAGE) assay (27, 28). Af-
ter the incubation of Ab40 with metallohelices at 37°C, we separated
the high–molecular weight Ab40 aggregates and the low–molecular
weight Ab40 species by centrifugation. The aggregated peptide pel-
lets were resuspended in sample buffer and then boiled with SDS for
10 min to destroy the secondary and tertiary structures. The total
amounts of aggregated Ab40 were estimated by the SDS-PAGE as-
say. After incubation with metallohelices A1 and B4, the amount ofGuan et al., Sci. Adv. 2018;4 : eaao6718 19 January 2018the resuspended peptide was decreased (fig. S6). SDS-PAGE results
indicated that these metallohelices inhibited Ab aggregation.
To further study the morphology of Ab40 and Ab42 aggregates
affected by these metallohelices, we carried out an atomic force mi-
croscopy (AFM) study (29, 30). In samples of Ab40 or Ab42 alone,
traditional nonbranched amyloid fibrils (helical filaments with diam-
eters of about 10 nm and lengths of up to several micrometers) were
observed (Fig. 3, control). After incubating Ab40 or Ab42 with the
metallohelices, particularly LB4, numerous small, globular dots can
be observed, suggesting the excellent efficacy of metallohelices in
inhibiting the aggregation of Ab40 and Ab42 (Fig. 3).
Ab40/Ab42 aggregation involves formation of b sheet–rich frame-
works, which can be determined by circular dichroism (CD; a wide
band near 217 nm). We calculated the proportional contribution of
the b sheet structure in the samples of Ab40 according to previous re-
ports (31, 32). On average, the Ab40 fibrils contained approximately
57± 5%of b sheet structure, which decreased to 29± 3%, 35± 4%, 19 ±
3%, and 23± 4%on incubationwithLA1,DA1,LB4, andDB4, respec-
tively (Fig. 4, A and B). As shown in fig. S7, the metallohelices had a
similar effect on Ab42. This indicates that the metallohelices inhibit
significant structural change inAb40. To reveal the enantiomeric selec-
tivity of metallohelix enantiomers, we performed dialysis experiments
(33). Racemic mixtures of A1 and B4 were dialyzed against Ab40. In
addition, the enhanced sign ofCDwas attributed to the left enantiomer
with lower binding affinity to Ab40. As shown in Fig. 4 (C and D), the
dialyzate was rich in DA1 and DB4, which unambiguously indicated
that LA1 and LB4 preferentially bind to Ab40 compared with their
enantiomers.
The fourmetallohelices showed different inhibiting capacities. To
have a better understanding of the inhibiting ability of the metallo-
helices, we determined the Ab40 binding affinity of metallohelices by
the fluorescence titration method (14, 34). With increasing amounts
of metallohelices, the fluorescence intensity of Ab40 was decreased
(fig. S8). The apparent binding constants (Ka) were extracted by a
nonlinear least-squares procedure. As shown in table S2, Ka values
ofLA1 andLB4 were 8.9-fold and 2.3-fold higher than those of their
D enantiomers. As previously reported, the Ka values of symmetric
complexes L1 and L2 are only 3.9 and 5.3 times higher than those of, 2018Fig. 3. AFM images of Ab40/Ab42 with or without the incubation of metallohelices (area corresponding to 3 mm × 3 mm). Control: 50 mM Ab40/Ab42 alone. LA1,
DA1, LB4, and DB4: 50 mM Ab40/Ab42 with the incubation of 50 mM LA1, DA1, LB4, and DB4.3 of 10
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 their enantiomers (table S2). Together, symmetric complexes showed
less chiral discrimination on Ab aggregation than asymmetric ones.
These results are in agreementwith the IC50 value of themetallohelices
against Ab40 aggregation. Therefore, we conjectured that the distinct
inhibition ability of these metallohelices mainly depended on the dif-
ferent affinities to Ab40. Although both symmetric and asymmetric
metallohelices have similar triple-helical structures, they presented
different Ab40 inhibition activities and binding affinities as a result
of their different spatial structures. Notably, although the affinities of
asymmetric metallohelices to Ab40 were not as strong as those of the
Ab antibody (35, 36), the chiral recognition between these enantiomers
was significant for targeting and inhibition of Ab40 aggregation.
The stoichiometry and binding constants between these new inhib-
itors and Ab40 were estimated by isothermal titration calorimetry
(ITC) (14). The ITC integrated heat data profiles were used to estimate
the binding parameters between Ab and LA1, between Ab and DA1,
betweenAb andLB4, and betweenAb and DB4. The binding was exo-
thermic according to the net enthalpy change (fig. S9) (37) and gave
the best fit to 1:1 binding. The thermodynamic parameters were sum-
marized in table S3, including the binding constant (Ka), enthalpy
change (DH), entropy change (DS), and Gibbs free energy change
(DG) upon the interaction between Ab and metallohelices. Binding
constants of LA1-Ab40, DA1-Ab40, LB4-Ab40, and DB4-Ab40 were
estimated to be 4.93 × 106, 5.36 × 105, 8.41 × 106, and 3.01 × 106, re-
spectively. These analyses further indicated thatLB4 hadmuch stron-
ger interactions to Ab40 than its enantiomer DB4.
Ab12–28 andAb25–35 fragments were used to explore the binding
site on Ab40. Given that the metallohelices have a similar size to short
a-helical peptides, it was considered that they may bind to the Ab13–
23 region. Because the cleavage site of Ab12–28 (lysine residues) was
involved in the central hydrophobic region, we chose this fragment as
the trypsin substrate for digestion experiments to verify our hypoth-
esis (16). Figure S10 shows that the digestion of Ab12–28 was pre-
vented by the presence of metallohelices, suggesting that they bindGuan et al., Sci. Adv. 2018;4 : eaao6718 19 January 2018to the a/b discordant stretch of Ab13–23. The band of Ab12–28 incu-
bated with compound B4 remained even stronger than that incubated
with A1, demonstrating that B4 bound to Ab40 more tightly than A1.
Furthermore, with the incubation of LA1, the band of Ab12–28 was
stronger than that with DA1, because the L enantiomer bound to
Ab40more tightly than theD one.On the other hand, previous reports
demonstrated that Ab25–35 can also form fibrils as Ab40 (38, 39).
However, the inhibition effect of these metallohelices on Ab25–35
was much weaker than that on Ab40 (fig. S11). The aggregation pro-
cess was not inhibited completely by the metallohelices even at a high
concentration; that is, they bind weakly to Ab25–35.
Nuclearmagnetic resonance (NMR) spectroscopywas further used
to study the binding site with Ab40 (40–42). The 1H NMR signals of
the aromatic rings (F19 and F20) (40, 41) of Ab40 changed signifi-
cantly upon the addition of A1, revealing that the triplex bound to the
central hydrophobic region of Ab40 (Fig. 5, A to D). Moreover, com-
paredwith theNMR spectrumofAb40 alone, obvious peak shifts were
observed with the incubation of A1 in 2.95 and 2.52 parts per million
owing to the amide protons of K16 and E22, respectively (Fig. 5, B
andC) (42, 43).LA1 induced the peaks tomove to downfield, whereas
DA1 led to a shift to upfield, suggesting a binding difference between
LA1 and DA1 with Ab40.
Fourier transform infrared (FTIR) spectroscopy is one of the pow-
erful methods to study the structure of peptides. Figure S12 shows the
FT-IR spectra of Ab40 under different conditions. The amide I and
amide II regions (1750 to 1500 cm−1) play a key role in analyzing
the second structure of the peptide. As shown in the FTIR spectra
of the Ab40 fibril, the signals at 1620 cm−1 can be assigned to anti-
parallel b sheets, whereas the band at 1680 cm−1 can be assigned to b
turns, in agreementwith previous reports (44, 45). ForAb40 incubated
withmetallohelices, the signals at 1620 cm−1 slightly shift to lower fre-
quencies. The band at 1650 cm−1 can be assigned to a helices, togetherFig. 4. The influenceofmetalloheliceson the structure ofAb40 and thebinding
affinity ofmetallohelices to Ab40. (A and B) CD spectra of Ab40without or with the
incubation of A1 (A) and B4 (B). (C and D) CD spectra of dialyzate were used to dis-
criminate the enrichment of the enantiomer with lower binding affinity to Ab40 in
competition dialysis experiments. The concentrations of metallohelices were 50 mM.Fig. 5. 1H NMR spectra of Ab40with orwithout treatment of A1. (A) The signals
caused by amide protons of K16, F19, F20, and E22 of Ab40. (B) Locally amplified
1H NMR spectra of peak a. (C) Locally amplified 1H NMR spectra of peak b. (D) The
peaks caused by the protons of F19 and F20 (black box) were obviously reduced
in intensity with treatment of A1. The chemical shift values of Ab40 were assigned
on the basis of previous studies (40–43).4 of 10
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 with a small contribution from random coils and unstructured con-
formations. As for the Ab40 monomer, the band around 1440 cm−1
can be assigned to His residues (46). After the conversion of the Ab40
monomer to fibril, His residues became involved in the b sheet struc-
ture and their vibrations became limited. Therefore, its vibrational
band can hardly be observed. With the incubation of metallohelices
(LA1 and DA1), the vibrational band of His residues is observable,
demonstrating that the metallohelices (LA1 and DA1) can inhibit
Ab to form b sheet structures and fibrils.
The above results revealed a prominent enantioselective interac-
tion between Ab40 and the chiral metallohelices. Arene units at the
terminus of themetallohelices featured parallel p-stacking interactions
and formed strong p surfaces. F19 or F20 in the central hydrophobic
region of Ab40 bound to the arene rings through hydrophobic inter-
actions and p-p stacking. p-p stacking plays an important role in Ab40
and affects the physical and chemical behaviors. In addition, the in-
teractions between Ab and the metallohelices may also involve His
residues (His13 and His14). The chirality of the a-helical structure and
L–amino acids of the peptideswould result in different hydrophobic and
p-p interactions between Ab40 and the D/L enantiomers. Furthermore,
the positive charge of the metallohelices also strengthens the binding
affinity to negatively charged Ab13–16 by electrostatic interactions.
To better understand and visualize the interactions responsible for
such binding of triplex metallohelices, we performed docking studies
based on the reported NMR structure of the Ab40 monomer [Protein
Data Bank (PDB) 2LFM] in aqueous solution using AutoDock Vina
(8, 47, 48). Under these conditions, the Ab40 peptide comprises a 310
helix structure in the 13 to 23 region (fig. S13) (43). Figure 6A and
fig. S14 show the resultant low-energy conformations of the Ab40-
metallohelix interactions. LB4 was parallel to the a helix, and the
binding was further stabilized by p-p stacking between F19 and
LB4 (Fig. 6, C and D). Although DB4 also formed p-p stacking with
residue F19 (Fig. 6, E and F), it was perpendicular to the a helix, and
the involved p-p stacking moiety was smaller than that of LB4. This
is at least consistent with the weaker binding and less potent inhibi-
tion observed in the above ITC and ThT studies. The docking studies
reported here are also in agreement with the NMR observation that
the triplex metallohelices bind to the hydrophobic region.Guan et al., Sci. Adv. 2018;4 : eaao6718 19 January 2018
, 2018It has been proposed that Ab aggregation–induced overgeneration
of reactive oxygen species (ROS), and the subsequent detrimental re-
actions with biomacromolecules including proteins, lipids, DNA, and
RNA in the cortex, is a factor in AD pathogenesis (49–51). Superoxide
dismutase (SOD) enzymes are promising pharmaceuticals in the treat-
ment of AD. In addition, it is well known that catalase and SODactivity
can be achieved by certain metal-containing model compounds, such
as iron porphyrins (52). Although the Fe(II) center in our metallo-
helices is highly stabilized in this oxidation state and fully encapsulated
in the structure, we know that imine complexes of redox-activemetals
can nevertheless be radical scavengers (53, 54). Therefore, we con-
jectured that the metallohelices used here may be delivering Fe ions
in such a form as to display SOD-like activity or are otherwise deplet-
ing harmful ROS.
The SOD activities of these metallohelices were estimated by a
modified nitro blue tetrazolium (NBT) assay system, 2,2-azinobis(3-
ethylbenzothiozoline)-6-sulfonic acid (ABTS) methodology, and
cyclic voltammetry (CV) (8, 55–57). With the irradiation of light,
NBT can be photochemically oxidized by the superoxide anion
produced by riboflavin. These metallohelices inhibit this process by
reducing the superoxide anion radical. Owing to the distinct absolute
configurations, the metallohelices showed different SOD mimic ac-
tivities (fig. S15A). Using the ABTS methodology (56), the results
also demonstrated that the metallohelices scavenged ROS effectively
(fig. S15, B to F). In addition, we also used CV to assess the reactivity
of metallohelices with superoxide (57). As shown in fig. S16, after the
addition of the metallohelix solution, the oxidation peak current of
O2
•− (Ipa: anodic current; oxygen regeneration) decreased, whereas the
reduction current (Ipc: cathodic current; O2
•− formation) was nearly
unchanged. These data indicated that the metallohelices reacted with
O2
•−; that is, they scavenged O2
•−. Next, we further studied the effects
of the metallohelices on superfluous ROS induced by the aggregation
of Ab40 in PC12 cells. Our data revealed that the metallohelices
effectively suppressed the Ab40-induced ROS production (fig. S17).
On the basis of these results, the metallohelices could serve as SOD
mimics or otherwise as free radical scavengers.
On the basis of the capacities of the metallohelices to inhibit
Ab40 assembly, these complexes might be helpful in protecting cells
from Ab-mediated toxicity. Therefore, we performed MTT [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide] assay to probe
the cellular metabolism of differentiated PC12 cells, which have been
proven to be more susceptible to neurotoxicity of Ab40 aggregations
than normal PC12 cells (29). Before the following experiments, the sta-
bility of the complex should be studied under physiological conditions.
Upon incubation in phosphate-buffered saline (PBS), the absorption
wavelength and the intensity of the metal-to-ligand charge transfer
bands of the metallohelices did not change (fig. S18), demonstrating
that the metallohelices were stable under our experimental conditions.
Further studies showed that A1 or B4 alone had little influence on PC12
cell viability (fig. S19). As shown in fig. S20, agedAb40 andAb42 caused
a decrease in cell viability. With the addition of A1 or B4, cell death can
be suppressed in a dose-dependent manner. As a result of the different
binding affinities to Ab40 andAb42, thesemetallohelices showed chiral
discrimination even in the culture medium. Although B4 displayed
higher binding affinity to Ab40, it only showed a lightly stronger pro-
tection effect than A1, suggesting that Ab-mediated cytotoxicity was
complicated when Ab40 and the metallohelices were incubated together.
The transgenic Caenorhabditis elegans (C. elegans) strain CL2006,
which expresses an Ab protein fragment involved in the developmentFig. 6. The interaction of Ab40 and B4 by docking study. (A and B) Energy-
minimized averagemodels ofLB4 (A) andDB4 (B) with Ab40 interactions. (C andD) Hydro-
phobic interaction between Ab40 and LB4 (C) and between Ab40 and DB4 (D). (E) Locally
amplified image of the black box in (C). (F) Locally amplified image of the black box in (D).5 of 10
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 of AD, is widely used in studying and developing drug effects (58, 59).
The strain shows a phenotype of Ab expression and aggregation in
muscle, leading to progressive paralysis. In untreated control C. elegans,
the worms were almost completely paralyzed within 12 days; by com-
parison, the paralysis rate induced by Ab was obviously postponed in
CL2006wormswith the treatment ofmetallohelices. Complete paralysis
occurred in 13 days with the incubation of DA1, whereas the worms
were completely paralyzed within 15 days withLA1 treatment (Fig. 7A).
In addition, both LB4 and DB4 can also delay the paralysis of CL2006
worms to about 16 days (Fig. 7B). These data show that metallohelix
treatment led to an increased life span in this strain.
Moreover, to investigate whether life-span extension was related to
Ab accumulation, thioflavin S (ThS) staining was performed to
estimate the amyloid levels in the CL2006 strain (59). N2 wild-type
strain wormwas used as a control, which did not express Ab transgene
or undergo paralysis. The fluorescent images of the head region are
shown in Fig. 7 (C to H). The images showed that metallohelix treat-
ment greatly inhibited Ab aggregation and deposition in the CL2006
strain compared with the untreated CL2006 worms. These findings
demonstrated that metallohelices extend the life span of C. elegans
by attenuating Ab-induced toxicity.
As potential therapeutic agents for the treatment of AD, these
metallohelices should cross the blood-brain barrier (BBB). Metallo-
helix permeability of the BBB is evaluated by the quantity of Fe in theGuan et al., Sci. Adv. 2018;4 : eaao6718 19 January 2018mouse brain through inductively coupled plasmamass spectrometry
(ICP-MS). Compared to the control mouse, a higher level of Fe can
be detected in the cerebrospinal fluid (CSF) of metallohelix-treated
mouse. About 1.68 and 0.82% for A1 and B4, respectively, can be
accumulated in the brain effectively, suggesting that these metallo-
helices had the ability to cross the BBB. Briefly, these metallohelices
can be potential candidates for AD treatment. Moreover, compared
with B4, A1 exhibited a stronger capability to cross the BBB.CONCLUSION
In summary, asymmetric triplex metallohelices have been demon-
strated to provide a new generation of chiral Ab inhibitors. Through
binding to a/b discordant stretches, these architecturally chiral species
show enantioselectivity in the inhibition of Ab42 aggregation, evi-
denced by fluorescent cell–based screening systems and multiple bio-
physical and biochemical techniques. In addition, the compounds can
cross the BBB and block Ab-mediated cellular toxicity. In vivo study
proved that these metallohelices extend the life span of the C. elegans
CL2006 strain by attenuatingAb-induced toxicity. Themodular nature
of the synthesis of these triplex systems will allow us to further tune the
chiral multivalent interactions we have begun here to characterize. Our
work indicates that these new generations of asymmetric chiral supra-
molecular complexes are viable as Ab inhibitors against AD. o
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ThT assay
After incubation for different times, samples of 50 mMAb40 with or
without 50 mM metallohelices were diluted 50-fold with 0.01 M
Hepes buffer containing 0.15 M NaCl (pH 7.3). A JASCO FP-6500
spectrofluorometer was used for the ThT fluorescence assay. [ThT] =
10 mM, lex = 444 nm, and lem = 482 nm.
Ab-ECFP fusion system
The ECFP and Ab1–42 coding sequences were connected through a
short linker DNA. The vector with Ab-linker-ECFP or linker-ECFP
transformed to Escherichia coli strain BL21 (DE3) and cultured in LB
medium with ampicillin (50 mg/ml) at 37°C. Metallohelices with dif-
ferent concentrations were mixed to the culture medium for 30 min.
Then, isopropyl-b-D-thio-galactoside (1mM)was added to the culture
medium to induce the expression of ECFP. The recombinant proteins
were expressed at 20°C for 3 hours. After measuring the optical den-
sity at 600 nm (OD600) of all the samples, theywere diluted toOD600 =
0.1. Fluorescence measurements were performed with a JASCO FP-
6500 spectrofluorimeter. lex = 433 nm.
CD studies
A JASCO J-810 spectropolarimeter was used to collect CD spectra. The
experiments were performed at 37°C using a quartz cell with a path
length of 1 mm. The spectra of the samples were an average of three
scans with a wavelength of 200 to 250 nm and a speed of 5 nm/min.
The experimental parameters were set as follows: response, 4 s; inter-
val, 0.1 nm. The samples of Ab and metallohelices were incubated in
0.01 M Hepes buffer with 0.15 M NaCl (pH 7.3) at 37°C for 7 days.
AFM studies
Ab40 with or without equimolar A1 or B4 treatment was incubated
at 37°C for 7 days. The Ab40 samples were diluted 50-fold to obtain aFig. 7. The effect of A1 and B4 on the life span and Ab plaques of the trans-
genic strain CL2006. (A andB) Kaplan-Meier survival curves of the transgenic strain
CL2006 treated with or without metallohelices. Plots are representative of three
independent experiments. (C toH) Representative images ofAb plaques in theworm’s
head region. Arrows indicate Ab deposits. (C) Transgenic worm CL2006. Transgenic
worm CL2006 with the incubation of LA1 (D) and LB4 (E). (F) Bristol N2 worm (wild
type). Transgenic worm CL2006 with the incubation of DA1 (G) and DB4 (H).6 of 10
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 concentration of 1mMwith deionizedH2O.Then, 0.05ml of the sample
was dropped on a newly prepared mica substrate. After incubating for
30 min, the substrate was washed twice with deionized H2O and dried
before AFM studies. Under ambient conditions, tapping mode was
used to obtain the images. [Ab40] = 50 mM.
Trypsin digestion of Ab12–28
Ab12–28 (20 mM, 10 ml) with or without the incubation of A1 and B4
(Ab12–28:[A1 or B4] = 1:1) was reacted with trypsin (0.1 mg/ml) at
37°C for 1 hour. Then, all peptide samples were mixed with SDS-
PAGE reducing sample buffer and boiled for 10 min. The SDS-PAGE
gels were run in tris-tricine buffer. Finally, the SDS-PAGE gel was
stained by silver.
Sedimentation and PAGE
Samples of 50 mMAb40 peptides were treated with or without 50 mM
metallohelices at 37°C for 7 days. The samples were centrifuged at
13,500 rpm for 20 min to separate the aggregated Ab40 peptide. The
pellets were resuspended and heated to 100°C after mixing the sample
buffer with SDS. Samples were run on a tris-tricine SDS gel (12%) for
1 hour at 100 V. Finally, the gel was stained by silver.
NMR spectroscopy
In NMRmeasurement, peptide samples were prepared in 0.01M tris
buffer (pH 7.3, containing 0.15 M NaCl) with 10% D2O added. The
concentration of Ab40 samples was 0.1 mM. The Ab40 samples
were treated with metallohelices LA1 and DA1 at 37°C for 2 hours.
AnNMR studywas performed on a BrukerAVANCENMR600MHz
spectrometer equipped with a triple-channel cryoprobe at 5°C.
[Metallohelices] = 0.1 mM.
FT-IR measurement
The concentration of the Ab40 peptide was 6 mg/ml in D2O. The
concentration of metallohelices was 1.4 mM in D2O. FT-IR spectra
were obtained by using a Bio-Rad FTS-40 spectrometer with a
HgCdTe detector. Solvent correction was performed by subtracting
a spectrum of D2O.
Docking studies
Weobtained the structure of the Ab40 from the PDB (NMR structure
in aqueous solution, PDB 2LFM). Specifically, the structures of Ab40
and the metallohelices (LA1, DA1, LB4, and DB4) were prepared by
using AutoDock Tools. The torsion angles of these metallohelices
were regarded as flexible. Binding calculations were carried out be-
tween Ab40 and the metallohelices by AutoDock Vina. In the dock-
ing study, the exhaustiveness for the docking runs was 400. The
starting positions of the metallohelices were randomly determined,
and 20 modes of docking were obtained during docking. Docked
models of the metallohelices with Ab40 were visualized using Dis-
covery Studio.
SOD activity measurement by NBT
The percent inhibition of the photoreduction of NBT can be used to
evaluate the SOD activities of the metallohelices. The solutions
containing 0.075 mM NBT, 13 mMmethionine, 0.02 mM riboflavin,
and metallohelices of various concentrations were prepared in 0.05 M
PBS (pH 7.8). The samples were irradiated with a lamp for 10 min at
room temperature. Immediately, the absorbance of the samples was
measured at 560 nmafter irradiation. The reactionmixture in an iden-Guan et al., Sci. Adv. 2018;4 : eaao6718 19 January 2018tical tube was kept in the dark, serving as a blank control. The inhibi-
tion ability was assessed using the following formula: inhibition (%) =
[(A0 – A)/A0] × 100, where A0 is the absorbance of the blank control
and A is the absorbance of the sample.
Cyclic voltammetry
The electrolytic medium was dimethyl sulfoxide (DMSO) in 100 mM
tetrabutylammonium hexafluorophosphate. CV studies were per-
formed with a stationary glassy carbon electrode as the working
electrode and platinum wire as the auxiliary electrode. The reference
electrode was a Ag/AgCl electrode in saturated KCl solution. Before
and after each measurement, we polished the surface of the electrode
with alumina powder (0.3 to 0.05 mm). The O2/O2
•− was measured at
0.1 V s−1 by using different metallohelices (20 mM) at 25°C. We
bubbled the O2 gas directly into the cell with DMSO for 20min. Dur-
ing the CV experiment, O2 was flushed over the cell solution using an
apparatus consisting of two flowmeters (Cole-Parmer 316 SS) for O2
and N2.
Fluorescence titrations
The experimental conditions were listed as follows: [Ab40] = 3 mM,
[metallohelices] = 0.5 to 7 mM, lex = 278 nm, and lem = 306 nm. The
binding constants were calculated according to the 1:1 binding stoi-
chiometric equation. To achieve the appropriate intensity values of
fluorescence, the inner filter effect needs to be corrected. Attenuation
of the excitation beam and emission signal causes the inner filter ef-
fect, because the absorption by fluorophore resulted in a decrease in
fluorescence intensity. The inner filter effect can be corrected with
the absorbance values. Using the following equation, the fluores-
cence data of the system can be corrected
Fcorr ¼ Fobs log1 ðAex þ AemÞ=2½ 
where Fcorr and Fobs are the corrected and observed intensity of flu-
orescence, respectively, and Aex and Aem are the absorbance at the
excitation and emission wavelength, respectively.
ITC studies
Titrationswere carried out in 10mMHepes buffer (pH 7.4, containing
150 mMNaCl). An ITC study was carried out on a Nano ITC System
(TA Instruments Inc.). Injections of 10-ml 0.45 mM metallohelices
(LA1, DA1, LB4, and DB4) were mixed by a computer-controlled
microsyringe at an interval of 10 min into the 0.020 mM Ab40 so-
lution, with stirring at 400 rpm at a constant temperature of 25°C.
NanoAnalyze software was used to analyze the experimental data
(TA Instruments Inc.). A blankmodel was used to correct the heat of
dilution. In addition, the experimental data were acquired by 25 in-
jections of 0.45 mM metallohelices into 1400 ml of Ab at a constant
temperature of 25°C. As a result of each 10-ml metallohelix injected
into the Ab40 aqueous solution, a heat-burst curve was obtained.
Stopped-flow experiments
Fluorescence stopped-flow experiments were performed by using an
SX20 Stopped-Flow Spectrometer (Applied Photophysics Limited).
The final concentration of Ab and metallohelices (LA1 and DA1)
was 25 mM. Fluorescence changes were monitored at 306 nm with
an excitation wavelength of 278 nm.7 of 10
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 ROS measurement of cells
PC12 cells froma rat pheochromocytoma (obtained from theAmerican
Type Culture Collection) were cultured on 24-well plates for 24 hours.
Then, samples of Ab40 and metallohelices were added to the culture
medium for 12 hours, and PC12 cells were treated with 0.050 mM
DCFH-DA (2′,7′-dichlorofluorescin diacetate). After incubating for
30 min, PC12 cells were washed three times with PBS. Intracellular
esterases catalyzed DCFH-DA to anionic DCFH to trap the probe
in the cells. The reaction of DCFH with ROS yielded DCF. The fluo-
rescence intensity of DCF was measured by flow cytometry.
MTT assay
PC12 cells from a rat pheochromocytoma were obtained from the
American Type Culture Collection. They were cultured in Dulbecco’s
minimum essential medium (Gibco) with 10% heat-inactivated horse
serum and 5% fetal bovine serum. PC12 cells were cultured in a humi-
dified atmosphere of 95% air and 5% CO2 at 37°C. Differentiated PC12
cells were obtained by adding nerve growth factor (50 mg/ml; Invitro-
gen). The PC12 cells were seeded at 3 × 104 cells per well on 96-well
plates for 24 hours. Ab40 (5 mM) aged in the absence or presence of
metallohelices was added into the cultured medium of differentiated
PC12 cells, and the cells were cultured for another 24 hours at 37°C.
Cytotoxicity was evaluated using the MTT method. Absorbance
values were measured with an automatic plate reader at 490 nm.
Three independent experiments were carried out for each group.
C. elegans strains
In our study, two kinds of nematodes were used, including the trans-
genic CL2006 strain and the N2 ancestral strain. Transfected CL2006
worms produce Ab3–42 in the body wall muscles constitutively. The
N2 strain is a wild-type strain. The nematode strains were fed with
E. coli (OP50) and propagated at 20°C on solid nematode growthme-
dium. To obtain age-synchronized worms, they were transferred to
fresh NGM plates after reaching maturity at 3 days. Then, they laid
eggs overnight. At day 1, isolated hatchlings were cultured on new
NGM plates at 20°C.
C. elegans paralysis assay
Strains (the N2 and CL2006 worms) were cultured at 20°C on new
NGM plates (35 × 10 mm culture plates, 50 worms per plate) after
egg synchronization. The strains were fed with OP50 E. coli. In the ex-
perimental group, the strains were fed with metallohelices (100 mM,
100 ml per plate) at the larval stage (including L1, L2, or L3), and pa-
ralysis was estimated at the L4 larval stage. When strains only moved
their head or did not move at all when gently touched with a platinum
loop, we classified them as paralyzed. Three independent trials were
performed.
Fluorescence staining of Ab deposits
For strain CL2006, synchronized populations were cultured in S-basal
liquidmedium containingmetallohelices (100 mM, 100 ml per plate) at
20°C. CL2006 worms were fixed in PBS (pH 7.4, containing 4% para-
formaldehyde) for 24 hours at 4°C and rendered permeable in per-
meabilization buffer [1% Triton X-100, 5% b-mercaptoethanol, and
0.125M tris (pH 7.4)] for another 24 hours at 37°C. After two washings
with PBS, the nematodes were immersed in 50% ethanol with 0.125%
ThS for 2 min, destained in 50% ethanol, mounted on slides, and ana-
lyzed by fluorescence images. At least three independent trials were
performed.Guan et al., Sci. Adv. 2018;4 : eaao6718 19 January 2018Handling of mice
Eight- to 12-week-old Wistar rats (sex-randomized) were used as test
animals. All animal experiments were carried out according to the
principles and procedures in “Regulations for the Administration of
Affairs Concerning Laboratory Animals” by the National Council of
China and “TheNational Regulation of China for Care andUse of Lab-
oratoryAnimals” by theNational Science andTechnologyCommission
of China. Protocols were approved by the Committee of JilinUniversity
Institutional Animal Care and Use. Wistar rats were dissected after
intraperitoneal injection of metal complexes for 4 hours. After anes-
thesia and exposure of the cisterna magna, CSF was obtained using
a glass-pulled micropipette, ensuring that the CSF was not contami-
nated with blood. About 10 ml of the CSF was obtained. The CSF
was immediately diluted 10-fold in 1% CHAPS (3-[(3-cholamido-
propyl)dimethylammonio]-1-propanesulfonate) in PBS with prote-
ase inhibitors (Roche Diagnostics). The iron content of the samples
was measured by ICP-MS (Varian 720-ES).SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/4/1/eaao6718/DC1
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